Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;39(4):633-41.
doi: 10.1007/s10865-016-9741-y. Epub 2016 Apr 9.

Measuring insulin adherence among adults with type 2 diabetes

Chandra Y Osborn  1 , Jeffery S Gonzalez  2   3
Affiliations

Measuring insulin adherence among adults with type 2 diabetes

Chandra Y Osborn et al. J Behav Med. 2016 Aug.

Erratum in

Abstract

Non-adherence to insulin is common and associated with suboptimal health. We adapted the Morisky Medication Adherence Scale to specify insulin adherence (MIAS) and compared it to the Adherence to Refills and Medication Scale for Diabetes (ARMS-D) and the Summary of Diabetes Self-Care Activities medications subscale (SDSCA-MS) and an insulin-specific (SDSCA-IS) version. A sample of 144 insulin-treated adults (58 % African American/Black, 34 % Caucasian/White, 8 % Other/Mixed race; 6.9 % Hispanic) completed these measures along with a HbA1C test. The internal consistency and factor structure of the MIAS were adequate; 59 % of participants forgot to take insulin and 46 % reported non-adherence. The MIAS was associated with the ARMS-D, SDSCA-MS, and SDSCA-IS (p < 0.001), and higher MIAS scores were marginally associated with better self-rated health (p = 0.057), but significantly associated with fewer emergency room visits (p = 0.001), and better HbA1C (p = 0.001). The MIAS is a valid and reliable insulin adherence assessment tool for practice and research applications.

Keywords: Insulin therapy; Measurement; Medication adherence; Type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Authors Chandra Y. Osborn and Jeffery S. Gonzalez declare that they have no conflict of interest.

The authors have no conflict of interests or financial disclosures to report.

References

    1. Al-Qazaz H, Hassali MA, Shafie AA, et al. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216–221. - PMC - PubMed
    1. Baek RN, Tanenbaum ML, Gonzalez JS. Diabetes burden and diabetes distress: the buffering effect of social support. Ann Behav Med. 2014;48(2):145–155. - PMC - PubMed
    1. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958–2971. - PubMed
    1. Chung WW, Chua SS, Lai PS, et al. The Malaysian Medication Adherence Scale (MALMAS): Concurrent validity using a clinical measure among people with type 2 diabetes in Malaysia. PLoS One. 2015;10(4):e0124275. - PMC - PubMed
    1. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224. - PubMed

Publication types

LinkOut - more resources